TCON
Closed
Tracon Pharmaceuticals Inc
0.0322
0.0000 (0.00%)
Last Update: 01 Jul 2025 16:30:00
Yesterday: 0.0322
Day's Range: 0.0322 - 0.0322
Send
sign up or login to leave a comment!
When Written:
2.01
TRACON Pharmaceuticals Inc is a biopharmaceutical company that develops and commercializes targeted therapies for cancer and other diseases. The company's pipeline includes product candidates for the treatment of solid tumors, hematologic malignancies, and rare diseases. Its lead product candidate is TRC105, a novel anti-angiogenesis agent being developed for the treatment of multiple solid tumor types. The company also has a collaboration agreement with Santen Pharmaceutical Co. Ltd. for the development and commercialization of TRC105 in ophthalmology indications. TRACON Pharmaceuticals Inc was founded in 2004 and is headquartered in San Diego, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








